Deal sells 9% senior secured notes, 2.25% senior secured convertibles
By Devika Patel
Knoxville, Tenn., June 23 – Mela Sciences, Inc. completed a $42.5 million private placement of 9% senior secured notes and 2.25% senior secured convertible debentures on June 22, according to an 8-K filed Tuesday with the Securities and Exchange Commission.
The $10 million notes mature on Nov. 30, 2015.
The $32.5 million convertibles mature in five years and are initially convertible into about 43.3 million common shares at $0.75 per share.
Investors also received five-year warrants for 3 million common shares, which are exercisable at $0.75.
The conversion price and strike price reflect a 56.9% discount to the June 19 closing share price of $1.74.
Proceeds were used to purchase the XTRAC and VTRAC laser business from PhotoMedex Inc. for $42.5 million.
Mela is a Irvington, N.Y., medical device company.
Issuer: | Mela Sciences, Inc.
|
Issue: | Senior secured notes and senior secured convertible debentures
|
Amount: | $42.5 million
|
Warrants: | For 3 million shares
|
Warrant expiration: | Five years
|
Warrant strike price: | $0.75
|
Settlement date: | June 22
|
Stock symbol: | Nasdaq: MELA
|
Stock price: | $1.74 at close June 19
|
Market capitalization: | $10.87 million
|
|
Notes
|
Amount: | $10 million
|
Maturity: | Nov. 30, 2015
|
Coupon: | 9%
|
|
Convertibles
|
Amount: | $32.5 million
|
Maturity: | Five years
|
Coupon: | 2.25%
|
Conversion price: | $0.75
|
Conversion ratio: | Into about 43.3 million shares
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.